421 related articles for article (PubMed ID: 6342687)
1. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
3. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
[TBL] [Abstract][Full Text] [Related]
4. A comparative ex vivo study of plasminogen activators and proteases for fibrinolytic activity and side effects in rabbits.
Janik BA; Papaioannou SE
Thromb Haemost; 1977 Feb; 37(1):154-61. PubMed ID: 576512
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolytic agents.
Schmitz-Huebner U; van de Loo J
Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785
[No Abstract] [Full Text] [Related]
6. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
Gurewich V; Pannell R
Thromb Haemost; 1987 Jun; 57(3):372-3. PubMed ID: 3116707
[No Abstract] [Full Text] [Related]
7. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
Bachmann F
Arzneimittelforschung; 1988 Mar; 38(3A):474-8. PubMed ID: 3134901
[TBL] [Abstract][Full Text] [Related]
8. Selective fibrinolytic activity of recombinant non-glycosylated human pro-urokinase (single-chain urokinase-type plasminogen activator) from bacteria.
Hanbücken FW; Schneider J; Günzler WA; Friderichs E; Giertz H; Flohé L
Arzneimittelforschung; 1987 Aug; 37(8):993-7. PubMed ID: 3118890
[TBL] [Abstract][Full Text] [Related]
9. [Fibrinolytic and thrombolytic effect of proteases from various fungal cultures].
Andreenko GW; Silaev AB; Maksimova RA; Poch LI; Serebrjakova TN
Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):14-21. PubMed ID: 4134256
[No Abstract] [Full Text] [Related]
10. [Tissue plasminogen activator].
Matsuo O
Rinsho Ketsueki; 1984 Jul; 25(7):1004-10. PubMed ID: 6542154
[No Abstract] [Full Text] [Related]
11. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
Veremeenko KN; Kizim AI
Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
[TBL] [Abstract][Full Text] [Related]
12. Serine-proteases as plasminogen activators in terms of fibrinolysis.
Flemmig M; Melzig MF
J Pharm Pharmacol; 2012 Aug; 64(8):1025-39. PubMed ID: 22775207
[TBL] [Abstract][Full Text] [Related]
13. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
[TBL] [Abstract][Full Text] [Related]
14. [A hybrid molecule of pro-urokinase and a fibrin-specific, monoclonal antibody fragment is a more effective thrombolytic agent than pro-urokinase in vitro and in vivo].
Bode C; Eberle T; Runge M; Haber E; Kübler W
Verh Dtsch Ges Inn Med; 1990; 96():1-3. PubMed ID: 2128723
[No Abstract] [Full Text] [Related]
15. Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
Thorsen S
Dan Med Bull; 1977 Oct; 24(5):189-206. PubMed ID: 908205
[No Abstract] [Full Text] [Related]
16. [Plasminogen activator from a kidney cell culture].
Andreenko GV; Egorov BB; Liaginskiĭ AV; Serebriakova TN; Podorol'skaia LV
Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (10):55-8. PubMed ID: 6686063
[TBL] [Abstract][Full Text] [Related]
17. [Plasminogen activation by tricholysin (Trichothecium roseatum protease) after its single and repeated intravenous administration to animals].
Serebriakova TN; Andreenko GV; Maksimova RA
Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (7):60-3. PubMed ID: 572711
[No Abstract] [Full Text] [Related]
18. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
Thorsen S; Astrup T
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
[No Abstract] [Full Text] [Related]
19. [Fibrinolytic system of animals repeatedly and chronically administered plasminogen tissue activator].
Shimonaeva EE; Liutova LV; Andreenko GV
Vopr Med Khim; 1981; 27(6):823-8. PubMed ID: 7199779
[TBL] [Abstract][Full Text] [Related]
20. [Combined thrombolysis by pharmacokinetically different plasminogen activators].
Maksimenko AV
Bioorg Khim; 1998 May; 24(5):376-80. PubMed ID: 9661792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
